{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:49:19Z","timestamp":1782254959950,"version":"3.54.5"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1016\/s0016-5085(99)70005-3","type":"journal-article","created":{"date-parts":[[2005,11,16]],"date-time":"2005-11-16T12:24:28Z","timestamp":1132143868000},"page":"1029-1034","source":"Crossref","is-referenced-by-count":593,"title":["Endoscopic and histological healing with infliximab anti\u2013tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial"],"prefix":"10.1016","volume":"116","author":[{"given":"Geert","family":"D'Haens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander","family":"Van Deventer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Van Hogezand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip","family":"Baert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Braakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schaible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Geboes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rutgeerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S0016-5085(99)70005-3_bib1","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0016-5085(90)90002-I","article-title":"Clinical, biological and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone","volume":"98","author":"Modigliani","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1136\/gut.35.2.231","article-title":"Correlations between clinical activity, endoscopic severity, and biological parameters in colonic and ileocolonic Crohn's disease. A multicenter prospective study of 121 cases","volume":"35","author":"Cellier","year":"1994","journal-title":"Gut"},{"key":"10.1016\/S0016-5085(99)70005-3_bib3","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/0016-5085(92)91725-J","article-title":"Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial","volume":"102","author":"Landi","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gut.31.3.325","article-title":"Glucocorticoid treatment in ileal Crohn's disease: relief of symptoms but not of endoscopically viewed inflammation","volume":"31","author":"Olaison","year":"1990","journal-title":"Gut"},{"key":"10.1016\/S0016-5085(99)70005-3_bib5","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/0016-5085(95)90747-5","article-title":"An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease","volume":"109","author":"Sandborn","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib6","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/S0016-5085(97)70027-1","article-title":"Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease","volume":"112","author":"D'Haens","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0016-5085(99)70005-3_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0016-5085(95)90277-5","article-title":"Treatment of Crohn's disease with anti\u2013tumor necrosis factor chimeric monoclonal antibody (cA2)","volume":"109","author":"Van Dullemen","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor \u03b1 for Crohn's disease","volume":"337","author":"Targan","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S0016-5085(99)70005-3_bib10","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/gut.30.7.983","article-title":"Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study","volume":"30","author":"Mary","year":"1989","journal-title":"Gut"},{"key":"10.1016\/S0016-5085(99)70005-3_bib11","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"D'Haens","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib12","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0016-5085(79)90384-6","article-title":"Rederived values of the eight coefficients of Crohn's disease activity index","volume":"77","author":"Best","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib13","first-page":"171","article-title":"Stricture formation in Crohn's disease: wound healing in the intestine","author":"Graham","year":"1994"},{"key":"10.1016\/S0016-5085(99)70005-3_bib14","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(78)92524-2","article-title":"Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease","volume":"2","author":"O'Donoghue","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/S0016-5085(99)70005-3_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/BF01070829","article-title":"A controlled trial of azathioprine in Crohn's disease","volume":"20","author":"Rosenberg","year":"1975","journal-title":"Am J Dig Dis"},{"key":"10.1016\/S0016-5085(99)70005-3_bib16","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/gut.37.5.674","article-title":"A controlled double blind study of azathioprine in the management of Crohn's disease","volume":"37","author":"Candy","year":"1995","journal-title":"Gut"},{"key":"10.1016\/S0016-5085(99)70005-3_bib17","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0140-6736(71)90268-6","article-title":"Controlled trial of azathioprine in Crohn's disease","volume":"2","author":"Willoughby","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/S0016-5085(99)70005-3_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","article-title":"Treatment of Crohn's disease with 6-mercaptopurine. A long-term randomized double-blind study","volume":"302","author":"Present","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/S0016-5085(99)70005-3_bib19","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2249.1990.tb03334.x","article-title":"Tumornecrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine","volume":"81","author":"MacDonald","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0016-5085(99)70005-3_bib20","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1136\/gut.34.12.1705","article-title":"Location of tumor necrosis factor \u03b1 by immunohistochemistry in chronic inflammatory bowel disease","volume":"34","author":"Murch","year":"1993","journal-title":"Gut"},{"key":"10.1016\/S0016-5085(99)70005-3_bib21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1365-2249.1995.tb08340.x","article-title":"Beneficial effects of tumor necrosis factor-\u03b1 blockade in rheumatoid arthritis","volume":"101","author":"Maini","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S0016-5085(99)70005-3_bib22","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1172\/JCI117394","article-title":"Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor\/CD3 complex: reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis","volume":"94","author":"Cope","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/S0016-5085(99)70005-3_bib23","doi-asserted-by":"crossref","first-page":"353","DOI":"10.7326\/0003-4819-110-5-353","article-title":"Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease","volume":"110","author":"Kozarek","year":"1989","journal-title":"Ann Intern Med"},{"key":"10.1016\/S0016-5085(99)70005-3_bib24","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2036.1994.tb00338.x","article-title":"Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease","volume":"8","author":"Beattie","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S0016-5085(99)70005-3_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00005176-199704000-00110","article-title":"Resolution of mucosal inflammation and fall in IL-1 beta mRNA in active Crohn's disease in response to polymeric diet CT3211 (abstr)","volume":"24","author":"Fell","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/S0016-5085(99)70005-3_bib26","first-page":"329","article-title":"Progress in understanding paediatric IBD problems","author":"Walker-Smith","year":"1995"},{"key":"10.1016\/S0016-5085(99)70005-3_bib27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5085(99)70224-6","article-title":"Tumor necrosis factor \u03b1 antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's ileocolitis","volume":"116","author":"Baert","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/S0016-5085(99)70005-3_bib28","first-page":"A1078","article-title":"Retreatment with anti-TNF-\u03b1 chimeric antibody (cA2) effectively maintains cA2-induced remission in Crohn's disease (abstr)","volume":"112","author":"Rutgeerts","year":"1997","journal-title":"Gastroenterology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508599700053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508599700053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,11]],"date-time":"2020-04-11T00:02:13Z","timestamp":1586563333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508599700053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S0016508599700053"],"URL":"https:\/\/doi.org\/10.1016\/s0016-5085(99)70005-3","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[1999,5]]}}}